13D/13G Filings - LENZ Therapeutics Inc. (LENZ)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-20
5:13 pm
Sale
2025-08-1813DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.1,400,220
4.900%
-175,679decrease
(-11.15%)
Filing
History
2025-07-14
4:50 pm
Sale
2025-07-1013DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.1,575,899
5.600%
-391,376decrease
(-19.89%)
Filing
History
2025-06-24
4:21 pm
Sale
2025-06-2013DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.1,967,275
7.000%
-133,924decrease
(-6.37%)
Filing
History
2025-06-12
4:49 pm
Unchanged
2025-06-1013DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.2,101,199
7.500%
0
(Unchanged)
Filing
History
2025-05-09
4:19 pm
Purchase
2025-05-0713DLENZ Therapeutics, Inc.
LENZ
RA Capital Management, L.P.4,260,606
15.100%
4,260,606increase
(New Position)
Filing
History
2025-03-27
4:21 pm
Purchase
2025-03-2013GLENZ Therapeutics, Inc.
LENZ
Paradigm BioCapital Advisors LP1,419,832
5.200%
1,419,832increase
(New Position)
Filing
History
2024-11-14
4:00 pm
Purchase
2024-09-3013GLENZ Therapeutics, Inc.
LENZ
TANG CAPITAL MANAGEMENT, LLC766,940
2.800%
766,940increase
(New Position)
Filing
History
2024-11-08
5:08 pm
Unchanged
2024-08-1413DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.2,101,199
7.600%
0
(Unchanged)
Filing
History
2024-07-29
4:12 pm
Purchase
2024-07-1713GLENZ Therapeutics, Inc.
LENZ
Ridgeback Capital Investments L.P.1,951,875
7.200%
1,951,875increase
(New Position)
Filing
History
2024-04-08
2:46 pm
Purchase
2024-03-2113GLENZ Therapeutics, Inc.
LENZ
EcoR1 Capital, LLC1,219,774
4.800%
1,219,774increase
(New Position)
Filing
History
2024-03-28
4:30 pm
Purchase
2024-03-2113GLENZ Therapeutics, Inc.
LENZ
Alpha Wave Ventures GP Ltd3,612,211
14.100%
3,612,211increase
(New Position)
Filing
History
2024-03-28
4:16 pm
Purchase
2024-03-2113DLENZ Therapeutics, Inc.
LENZ
RA Capital Management, L.P.4,250,856
16.600%
4,250,856increase
(New Position)
Filing
History
2024-03-25
8:42 pm
Purchase
2024-03-2113GLENZ Therapeutics, Inc.
LENZ
Samsara BioCapital, L.P. 1,213,865
4.800%
1,213,865increase
(New Position)
Filing
History
2024-03-25
4:43 pm
Purchase
2024-03-2113DLENZ Therapeutics, Inc.
LENZ
Versant Venture Capital VI L.P.2,101,199
8.200%
2,101,199increase
(New Position)
Filing
History
2024-03-25
4:33 pm
Purchase
2024-03-2113GLENZ Therapeutics, Inc.
LENZ
Point72 Asset Management, L.P.1,882,693
7.400%
1,882,693increase
(New Position)
Filing
History
2024-02-05
4:48 pm
Purchase
2024-01-2413GGraphite Bio, Inc.
GRPH
TANG CAPITAL PARTNERS LP445,406
5.400%
445,406increase
(New Position)
Filing
History
2024-02-05
4:31 pm
Purchase
2023-12-3113GGraphite Bio, Inc.
GRPH
Porteus Matthew506,933
6.100%
2,857increase
(+0.57%)
Filing
History
2023-11-17
4:38 pm
Unchanged
2023-11-1413DGraphite Bio, Inc.
GRPH
Versant Venture Capital VI L.P.2,101,200
25.400%
0
(Unchanged)
Filing
History
2023-02-14
5:07 pm
Purchase
2022-12-3113GGraphite Bio, Inc.
GRPH
Samsara BioCapital, L.P. 1,213,867
14.600%
92,162increase
(+8.22%)
Filing
History
2023-01-09
4:26 pm
Purchase
2023-01-0613GGraphite Bio, Inc.
GRPH
EcoR1 Capital, LLC1,219,778
14.700%
403,764increase
(+49.48%)
Filing
History
Goto 0, 1, Next